Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXAHALER budesonide-salmeterol versus Symbicort Turbuhaler in persistent asthma
2008-004833-70Phase 3Completed
- Sponsor
- SMB Laboratoires
- Start
- Jan 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide, salmeterol and formoterol in persistent asthma and asthma (2 arms), sponsored by SMB Laboratoires. Primary endpoint: Primary efficacy variable. Started Jan 2009; status: completed.
02
Drugs
budesonidesalmeterolformoterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2008-004833-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004833-70.